Transcript · English
Clinical Trials of Mebendazole for Cancer
Did you know that there are seven clinical trials involving
mebendazole and
cancer? Two of them were done by Johns Hopkins,
one of them was done in New
York, and a number of trials were done overseas.
Now, the Johns Hopkins trials are fascinating.
They looked at doses of mebendazole that were
twenty-five milligrams per kilogram, fifty milligrams per kilogram, a hundred
milligrams per kilogram, and two hundred milligrams per kilogram.
Do you know what dose they first started finding toxicity in,
like significant toxicity?
Two hundred milligrams per kilogram. And you know what that translates to?
If you take, take an average sixty-kilogram person,
that's
twelve thousand milligrams of mebendazole a day.
Twelve thousand. Now, you hear oncologists complaining
about liver toxicity on fenbendazole doses of
five hundred milligrams a day or a thousand milligrams a day,
but Johns Hopkins
found safety up to twelve thousand milligrams a day.
End of transcript · 152 words · machine translated